1. Home
  2. JVA vs SNTI Comparison

JVA vs SNTI Comparison

Compare JVA & SNTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Coffee Holding Co. Inc.

JVA

Coffee Holding Co. Inc.

HOLD

Current Price

$4.04

Market Cap

20.2M

ML Signal

HOLD

Logo Senti Biosciences Inc.

SNTI

Senti Biosciences Inc.

HOLD

Current Price

$0.34

Market Cap

10.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JVA
SNTI
Founded
1971
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Packaged Foods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
20.2M
10.4M
IPO Year
1997
2021

Fundamental Metrics

Financial Performance
Metric
JVA
SNTI
Price
$4.04
$0.34
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$8.50
AVG Volume (30 Days)
65.6K
127.0K
Earning Date
06-12-2026
05-06-2026
Dividend Yield
1.71%
N/A
EPS Growth
N/A
77.31
EPS
0.68
N/A
Revenue
$90,655,294.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$6.09
N/A
Revenue Growth
17.54
N/A
52 Week Low
$2.93
$0.29
52 Week High
$5.03
$2.88

Technical Indicators

Market Signals
Indicator
JVA
SNTI
Relative Strength Index (RSI) 68.65 42.48
Support Level $3.95 $0.29
Resistance Level $4.82 $0.40
Average True Range (ATR) 0.15 0.02
MACD 0.05 0.01
Stochastic Oscillator 86.26 45.39

Price Performance

Historical Comparison
JVA
SNTI

About JVA Coffee Holding Co. Inc.

Coffee Holding Co Inc is engaged in wholesale coffee operations, including manufacturing, roasting, packaging, marketing, and distributing roasted and blended coffees for privately labeled accounts and its brands, and it sells green coffee. The Company also manufactures and sells coffee roasters. Its products include wholesale green coffee, private-label coffee, and branded coffee. The company sells its coffee products throughout the United States, Canada, and certain Asian countries. The group's services are Custom Blending, Food Service Programs, and Private Label Services.

About SNTI Senti Biosciences Inc.

Senti Biosciences Holdings Inc, formerly known as Senti Biosciences Inc, is a clinical-stage biotechnology company developing cell and gene therapies using its gene circuit platform for patients with incurable diseases. Its gene circuits, created from proprietary DNA sequences, are designed to reprogram cells to sense, compute, and respond to cellular environments. Its product candidates are to kill cancer cells, spare healthy cells, increase specificity, and control drug expression. Its candidate, SENTI-202, is a logic-gated off-the-shelf CAR-NK cell therapy for blood cancers, currently in a Phase 1 clinical trial in the United States and Australia for relapsed or refractory hematological malignancies, including Acute Myeloid Leukemia (AML).

Share on Social Networks: